212 related articles for article (PubMed ID: 14614460)
1. Alterations in the common fragile site gene Parkin in ovarian and other cancers.
Denison SR; Wang F; Becker NA; Schüle B; Kock N; Phillips LA; Klein C; Smith DI
Oncogene; 2003 Nov; 22(51):8370-8. PubMed ID: 14614460
[TBL] [Abstract][Full Text] [Related]
2. Parkin gene alterations in hepatocellular carcinoma.
Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
[TBL] [Abstract][Full Text] [Related]
3. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.
Cesari R; Martin ES; Calin GA; Pentimalli F; Bichi R; McAdams H; Trapasso F; Drusco A; Shimizu M; Masciullo V; D'Andrilli G; Scambia G; Picchio MC; Alder H; Godwin AK; Croce CM
Proc Natl Acad Sci U S A; 2003 May; 100(10):5956-61. PubMed ID: 12719539
[TBL] [Abstract][Full Text] [Related]
4. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer.
Denison SR; Callahan G; Becker NA; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2003 Sep; 38(1):40-52. PubMed ID: 12874785
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
Picchio MC; Martin ES; Cesari R; Calin GA; Yendamuri S; Kuroki T; Pentimalli F; Sarti M; Yoder K; Kaiser LR; Fishel R; Croce CM
Clin Cancer Res; 2004 Apr; 10(8):2720-4. PubMed ID: 15102676
[TBL] [Abstract][Full Text] [Related]
6. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
7. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
8. Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.
Elfferich P; Verleun-Mooijman MC; Maat-Kievit JA; van de Warrenburg BP; Abdo WF; Eshuis SA; Leenders KL; Hovestadt A; Zijlmans JC; Stroy JP; van Swieten JC; Boon AJ; van Engelen K; Verschuuren-Bemelmans CC; Lesnik-Oberstein SA; Tassorelli C; Lopiano L; Bonifati V; Dooijes D; van Minkelen R
Neurogenetics; 2011 Nov; 12(4):263-71. PubMed ID: 21993715
[TBL] [Abstract][Full Text] [Related]
9. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
[TBL] [Abstract][Full Text] [Related]
10. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
[TBL] [Abstract][Full Text] [Related]
11. A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.
Li D; Aung-Htut MT; Ham KA; Fletcher S; Wilton SD
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019779
[TBL] [Abstract][Full Text] [Related]
12. WWOX, the common chromosomal fragile site, FRA16D, cancer gene.
Ludes-Meyers JH; Bednarek AK; Popescu NC; Bedford M; Aldaz CM
Cytogenet Genome Res; 2003; 100(1-4):101-10. PubMed ID: 14526170
[TBL] [Abstract][Full Text] [Related]
13. WWOX, large common fragile site genes, and cancer.
Gao G; Smith DI
Exp Biol Med (Maywood); 2015 Mar; 240(3):285-95. PubMed ID: 25595185
[TBL] [Abstract][Full Text] [Related]
14. Alterations of common chromosome fragile sites in hematopoietic malignancies.
Ishii H; Furukawa Y
Int J Hematol; 2004 Apr; 79(3):238-42. PubMed ID: 15168591
[TBL] [Abstract][Full Text] [Related]
15. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
Sinha R; Racette B; Perlmutter JS; Parsian A
Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
[TBL] [Abstract][Full Text] [Related]
18. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
19. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Letessier A; Garrido-Urbani S; Ginestier C; Fournier G; Esterni B; Monville F; Adélaïde J; Geneix J; Xerri L; Dubreuil P; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M; Chaffanet M
Oncogene; 2007 Jan; 26(2):298-307. PubMed ID: 16819513
[TBL] [Abstract][Full Text] [Related]
20. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
